Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page
- Check5 days agoChange DetectedThe page now includes a Locations section with North Holland (Amsterdam UMC, location VUmc); the old North Holland Locations header was removed and the footer HHS Vulnerability Disclosure link was removed, with revision tag updated to v3.3.3.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedThe additions include an automated PubMed publications note and a revision tag (Revision: v3.3.2). The deletions remove the older PubMed note and the previous revision tag (Revision: v3.2.0).SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved the funding-status notice that warned about potential delays in updating information due to government funding. This does not modify the study details, eligibility criteria, or outcomes listed on the page.SummaryDifference0.3%

- Check55 days agoChange DetectedThe new screenshot shows minor layout and styling tweaks that do not modify study content, eligibility criteria, locations, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedMajor change: new version v3.2.0 plus a government operating status notice; removal of v3.1.0 indicates the update to the latest release.SummaryDifference2%

- Check90 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.